Table: Kringle Pharma - 9-MTH parent results

Kringle Pharma

08/08/2025 07:41

Aug 8 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Jun 30, 2025        Jun 30, 2024       Sep 30, 2025  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            53 mln              61 mln             71 mln     
                 (-12.4 pct)         (+19.3 pct)       (-10.2 pct)   
  Operating     loss 738 mln        loss 579 mln       loss 939 mln  
  Recurring     loss 738 mln        loss 517 mln       loss 945 mln  
  Net           loss 739 mln        loss 518 mln       loss 946 mln  
  EPS          loss 108.35 yen     loss 82.76 yen    loss 138.66 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T